Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 15, 2006 - Issue 3
Submit an article Journal homepage
269
Views
55
CrossRef citations to date
0
Altmetric
Review

The potential use of selective 5-HT2C agonists in treating obesity

Brian M Smith Arena Pharmaceuticals Research & Development, 6166 Nancy Ridge Drive, San Diego, CA 92121, USA . [email protected]
,
William J Thomsen Arena Pharmaceuticals Research & Development, 6166 Nancy Ridge Drive, San Diego, CA 92121, USA . [email protected]
&
Andrew J Grottick Arena Pharmaceuticals Research & Development, 6166 Nancy Ridge Drive, San Diego, CA 92121, USA . [email protected]
Pages 257-266 | Published online: 27 Feb 2006

Citations (55)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Kirsty Kiezebrink, Evleen T. Mann, Sarah R. Bujac, Michael J. Stubbins, David A. Campbell & John E. Blundell. (2010) Evidence of complex involvement of serotonergic genes with restrictive and binge purge subtypes of anorexia nervosa. The World Journal of Biological Psychiatry 11:6, pages 824-833.
Read now
Richard B Rothman & Michael H Baumann. (2009) Serotonergic drugs and valvular heart disease. Expert Opinion on Drug Safety 8:3, pages 317-329.
Read now
Ranjan Chakrabarti. (2009) Pharmacotherapy of obesity: emerging drugs and targets. Expert Opinion on Therapeutic Targets 13:2, pages 195-207.
Read now
Robert F Kushner. (2008) Anti-obesity drugs. Expert Opinion on Pharmacotherapy 9:8, pages 1339-1350.
Read now

Articles from other publishers (51)

Hari K. Namballa, Sudharshan Madapa, Dilep K. Sigalapalli & Wayne W. Harding. (2022) Semisynthetic Transformations on (+)-Boldine Reveal a 5-HT 2A/2C R Antagonist . Journal of Natural Products 85:9, pages 2149-2158.
Crossref
Mohammad Amin Langarizadeh, Khalil Eskandari, Ardavan Abiri, Marziye Ranjbar Tavakoli, Ali Asadipour & Yaghoub Pourshojaei. (2022) A novel dual three and five-component reactions between dimedone, aryl aldehydes, and 1-naphthylamine: synthesis and computational studies. Journal of Molecular Structure 1258, pages 132569.
Crossref
Meghan J. Orr, Andrew B. Cao, Charles Tiancheng Wang, Arsen Gaisin, Adam Csakai, Alec P. Friswold, Herbert Y. Meltzer, John D. McCorvy & Karl A. Scheidt. (2022) Discovery of Highly Potent Serotonin 5-HT 2 Receptor Agonists Inspired by Heteroyohimbine Natural Products . ACS Medicinal Chemistry Letters 13:4, pages 648-657.
Crossref
Richa Pant, Priyanka Firmal, Vibhuti Kumar Shah, Aftab Alam & Samit Chattopadhyay. (2021) Epigenetic Regulation of Adipogenesis in Development of Metabolic Syndrome. Frontiers in Cell and Developmental Biology 8.
Crossref
Paola Maccioni, Irene Lorrai, Federica Fara, Mauro A M Carai, Gian Luigi Gessa, Young-Won Chin, Jung Hwan Lee, Hak Cheol Kwon, Federico Corelli & Giancarlo Colombo. (2020) Differential Effects of Saikosaponins A, B2, B4, C and D on Alcohol and Chocolate Self-Administration in Rats. Alcohol and Alcoholism 55:4, pages 367-373.
Crossref
Qi Mao, Bingjie Zhang, Wanwan Li, Sheng Tian, Wenqing Shui & Na Ye. (2020) Identification of Novel 1- O -Substituted Aporphine Analogues as Potent 5-HT 2C Receptor Agonists . ACS Chemical Neuroscience 11:4, pages 549-559.
Crossref
Yulong Xu, Anna W. Sromek & John L. Neumeyer. (2019) Identification of fluorinated (R)-(−)-aporphine derivatives as potent and selective ligands at serotonin 5-HT2C receptor. Bioorganic & Medicinal Chemistry Letters 29:2, pages 230-233.
Crossref
Paola Maccioni, Federica Fara, Gian Luigi Gessa, Mauro A. M. Carai, Young-Won Chin, Jung Hwan Lee, Hak Cheol Kwon & Giancarlo Colombo. (2018) Reducing Effect of Saikosaponin A, an Active Ingredient of Bupleurum falcatum, on Intake of Highly Palatable Food in a Rat Model of Overeating. Frontiers in Psychiatry 9.
Crossref
Robert F. Kushner. (2018) Weight Loss Strategies for Treatment of Obesity: Lifestyle Management and Pharmacotherapy. Progress in Cardiovascular Diseases 61:2, pages 246-252.
Crossref
Guiping Zhang, Jianjun Cheng, John D. McCorvy, Paul J. Lorello, Barbara J. Caldarone, Bryan L. Roth & Alan P. Kozikowski. (2017) Discovery of N -Substituted (2-Phenylcyclopropyl)methylamines as Functionally Selective Serotonin 2C Receptor Agonists for Potential Use as Antipsychotic Medications . Journal of Medicinal Chemistry 60:14, pages 6273-6288.
Crossref
Thomas O. Schrader, Michelle Kasem, Albert Ren, Konrad Feichtinger, Bilal Al Doori, Jing Wei, Chunrui Wu, Huong Dang, Minh Le, Joel Gatlin, Kelli Chase, Jenny Dong, Kevin T. Whelan, Carleton Sage, Andrew J. Grottick & Graeme Semple. (2016) Tetrahydroquinoline-based tricyclic amines as potent and selective agonists of the 5-HT 2C receptor. Bioorganic & Medicinal Chemistry Letters 26:24, pages 5877-5882.
Crossref
Martin P. Green, Gordon McMurray & R. Ian Storer. (2016) Selective 5-HT2C receptor agonists: Design and synthesis of pyridazine-fused azepines. Bioorganic & Medicinal Chemistry Letters 26:16, pages 4117-4121.
Crossref
Navnit Prajapati, Rajani Giridhar, Anshuman Sinha, Ashish M. Kanhed & Mange Ram Yadav. (2015) Regioselective alkylation of 1,3,4,5-tetrahydrobenzo[d]azepin-2-one and biological evaluation of the resulting alkylated products as potentially selective $$\hbox {5-HT}_{\mathrm{2C}}$$ 5-HT 2 C agonists. Molecular Diversity 19:4, pages 653-667.
Crossref
Mahesh Shidore, Jatin Machhi, Prashant Murumkar, Mahesh Barmade, Jigar Thanki & Mange Ram Yadav. (2015) 3-Substituted 1-methyl-3-benzazepin-2-ones as 5-HT 2C receptor agonists . RSC Advances 5:111, pages 91908-91921.
Crossref
R.I. Versteeg, M.J. Serlie, A. Kalsbeek & S.E. la Fleur. (2015) Serotonin, a possible intermediate between disturbed circadian rhythms and metabolic disease. Neuroscience 301, pages 155-167.
Crossref
Jianjun Cheng, Patrick M. Giguere, Wei Lv, Bryan L. Roth & Alan P. Kozikowski. (2015) Design and synthesis of (2-(5-chloro-2,2-dimethyl-2,3-dihydrobenzofuran-7-yl)cyclopropyl)methanamine as a selective serotonin 2C agonist. Tetrahedron Letters 56:23, pages 3420-3422.
Crossref
Yifan Zhang, Angéla Kecskés, Daniëlle Copmans, Mélanie Langlois, Alexander D. Crawford, Berten Ceulemans, Lieven Lagae, Peter A. M. de Witte & Camila V. Esguerra. (2015) Pharmacological Characterization of an Antisense Knockdown Zebrafish Model of Dravet Syndrome: Inhibition of Epileptic Seizures by the Serotonin Agonist Fenfluramine. PLOS ONE 10:5, pages e0125898.
Crossref
Jianjun Cheng, Patrick M. Giguère, Oluseye K. Onajole, Wei Lv, Arsen Gaisin, Hendra Gunosewoyo, Claire M. Schmerberg, Vladimir M. Pogorelov, Ramona M. Rodriguiz, Giulio Vistoli, William C. Wetsel, Bryan L. Roth & Alan P. Kozikowski. (2015) Optimization of 2-Phenylcyclopropylmethylamines as Selective Serotonin 2C Receptor Agonists and Their Evaluation as Potential Antipsychotic Agents. Journal of Medicinal Chemistry 58:4, pages 1992-2002.
Crossref
SHELDON H. PRESKORN. (2014) CNS Drug Development. Journal of Psychiatric Practice 20:6, pages 460-465.
Crossref
L. M. Kozhevnikova, A. A. Moskovtsev & M. V. Mesitov. (2014) The effects of inhibitors of Rho- and tyrosine c-Src-kinases on serotonin-induced constrictions of the aorta and mesenteric artery in rats. Biology Bulletin 41:5, pages 452-460.
Crossref
R. Ian Storer, Paul E. Brennan, Alan D. Brown, Peter J. Bungay, Kelly M. Conlon, Matthew S. Corbett, Robert P. DePianta, Paul V. Fish, Alexander Heifetz, Danny K. H. Ho, Alan S. Jessiman, Gordon McMurray, Cesar Augusto F. de Oliveira, Lee R. Roberts, James A. Root, Veerabahu Shanmugasundaram, Michael J. Shapiro, Melanie Skerten, Dominique Westbrook, Simon Wheeler, Gavin A. Whitlock & John Wright. (2014) Multiparameter Optimization in CNS Drug Discovery: Design of Pyrimido[4,5- d ]azepines as Potent 5-Hydroxytryptamine 2C (5-HT 2C ) Receptor Agonists with Exquisite Functional Selectivity over 5-HT 2A and 5-HT 2B Receptors . Journal of Medicinal Chemistry 57:12, pages 5258-5269.
Crossref
Robert F. Kushner. (2014) Weight Loss Strategies for Treatment of Obesity. Progress in Cardiovascular Diseases 56:4, pages 465-472.
Crossref
Guohua Zhao, Chet Kwon, Sharon N. Bisaha, Philip D. Stein, Karen A. Rossi, Xueying Cao, Thao Ung, Ginger Wu, Chen-Pin Hung, Sarah E. Malmstrom, Ge Zhang, Qinling Qu, Jinping Gan, William J. Keim, Mary Jane Cullen, Kenneth W. Rohrbach, James Devenny, Mary Ann Pelleymounter, Keith J. Miller & Jeffrey A. Robl. (2013) Synthesis and SAR of potent and selective tetrahydropyrazinoisoquinolinone 5-HT2C receptor agonists. Bioorganic & Medicinal Chemistry Letters 23:13, pages 3914-3919.
Crossref
Robert F. Kushner. (2012) Pharmacologic management of obesity. Pediatric Blood & Cancer 58:1, pages 140-143.
Crossref
Kathryn M. Hurren & Helen D. Berlie. (2011) Lorcaserin: An investigational serotonin 2C agonist for weight loss. American Journal of Health-System Pharmacy 68:21, pages 2029-2037.
Crossref
Asif Ahmed, Shanthi Nagarajan, Munikumar Reddy Doddareddy, Yong-Seo Cho & Ae-Nim Pae. (2011) Binding Mode Prediction of 5-Hydroxytryptamine 2C Receptor Ligands by Homology Modeling and Molecular Docking Analysis. Bulletin of the Korean Chemical Society 32:6, pages 2008-2014.
Crossref
Mark D. Andrews, Paul V. Fish, Julian Blagg, Tiffini K. Brabham, Paul E. Brennan, Alison Bridgeland, Alan D. Brown, Peter J. Bungay, Kelly M. Conlon, Nicholas J. Edmunds, Kerry af Forselles, Colleen P. Gibbons, Martin P. Green, Giles Hanton, Mark Holbrook, Alan S. Jessiman, Karin McIntosh, Gordon McMurray, Carly L. Nichols, James A. Root, R. Ian Storer, Michael R. Sutton, Robin V. Ward, Dominique Westbrook & Gavin A. Whitlock. (2011) Pyrimido[4,5-d]azepines as potent and selective 5-HT2C receptor agonists: Design, synthesis, and evaluation of PF-3246799 as a treatment for urinary incontinence. Bioorganic & Medicinal Chemistry Letters 21:9, pages 2715-2720.
Crossref
Bruce J Sargent & Alan J Henderson. (2011) Targeting 5-HT receptors for the treatment of obesity. Current Opinion in Pharmacology 11:1, pages 52-58.
Crossref
Michele Fornaro. (2011) Switching from serotonin reuptake inhibitors to agomelatine in patients with refractory obsessive-compulsive disorder: a 3 month follow-up case series. Annals of General Psychiatry 10:1, pages 5.
Crossref
Heather Tye, Stephan G. Mueller, Juergen Prestle, Stefan Scheuerer, Marcus Schindler, Bernd Nosse, Natacha Prevost, Christopher J. Brown, Alexander Heifetz, Clemens Moeller, Anna Pedret-Dunn & Mark Whittaker. (2011) Novel 6,7,8,9-tetrahydro-5H-1,4,7,10a-tetraaza-cyclohepta[f]indene analogues as potent and selective 5-HT2C agonists for the treatment of metabolic disorders. Bioorganic & Medicinal Chemistry Letters 21:1, pages 34-37.
Crossref
Keith J MillerDean A Wacker. (2010) Discovery and development of 5-HT 2C receptor agonists for obesity: is there light at the end of the tunnel? . Future Medicinal Chemistry 2:12, pages 1761-1775.
Crossref
Richard B Rothman. (2010) Treatment of Obesity With “Combination” Pharmacotherapy. American Journal of Therapeutics 17:6, pages 596-603.
Crossref
William L. Hasler. (2009) Serotonin and the GI tract. Current Gastroenterology Reports 11:5, pages 383-391.
Crossref
Richard B Rothman & Michael H Baumann. (2009) Appetite Suppressants, Cardiac Valve Disease and Combination Pharmacotherapy. American Journal of Therapeutics 16:4, pages 354-364.
Crossref
Paul V. Fish, Alan D. Brown, Edel Evrard & Lee R. Roberts. (2009) 7-Sulfonamido-3-benzazepines as potent and selective 5-HT2C receptor agonists: Hit-to-lead optimization. Bioorganic & Medicinal Chemistry Letters 19:7, pages 1871-1875.
Crossref
Alastair S. Garfield & Lora K. Heisler. (2009) Pharmacological targeting of the serotonergic system for the treatment of obesity. The Journal of Physiology 587:1, pages 49-60.
Crossref
Richard B. Rothman, Dorota Zolkowska & Michael H. Baumann. (2008) Serotonin (5-HT) Transporter Ligands Affect Plasma 5-HT in Rats. Annals of the New York Academy of Sciences 1139:1, pages 268-284.
Crossref
Regina C. Casper, Elinor L. Sullivan & Laurence Tecott. (2008) Relevance of animal models to human eating disorders and obesity. Psychopharmacology 199:3, pages 313-329.
Crossref
William J. Thomsen, Andrew J. Grottick, Frederique Menzaghi, Hazel Reyes-Saldana, Stephen Espitia, Diane Yuskin, Kevin Whelan, Michael Martin, Michael Morgan, Weichao Chen, Hussien Al-Shamma, Brian Smith, Derek Chalmers & Dominic Behan. (2008) Lorcaserin, a Novel Selective Human 5-Hydroxytryptamine 2C Agonist: in Vitro and in Vivo Pharmacological Characterization . Journal of Pharmacology and Experimental Therapeutics 325:2, pages 577-587.
Crossref
David E. Nichols & Charles D. Nichols. (2008) Serotonin Receptors. Chemical Reviews 108:5, pages 1614-1641.
Crossref
Dorota Zolkowska, Michael H. Baumann & Richard B. Rothman. (2008) Chronic Fenfluramine Administration Increases Plasma Serotonin (5-Hydroxytryptamine) to Nontoxic Levels. Journal of Pharmacology and Experimental Therapeutics 324:2, pages 791-797.
Crossref
Brian M. Smith, Jeffrey M. Smith, James H. Tsai, Jeffrey A. Schultz, Charles A. Gilson, Scott A. Estrada, Rita R. Chen, Douglas M. Park, Emily B. Prieto, Charlemagne S. Gallardo, Dipanjan Sengupta, Peter I. Dosa, Jon A. Covel, Albert Ren, Robert R. Webb, Nigel R. A. Beeley, Michael Martin, Michael Morgan, Stephen Espitia, Hazel R. Saldana, Christina Bjenning, Kevin T. Whelan, Andrew J. Grottick, Frederique Menzaghi & William J. Thomsen. (2007) Discovery and Structure−Activity Relationship of (1 R )-8-Chloro-2,3,4,5-tetrahydro-1-methyl-1 H -3-benzazepine (Lorcaserin), a Selective Serotonin 5-HT 2C Receptor Agonist for the Treatment of Obesity . Journal of Medicinal Chemistry 51:2, pages 305-313.
Crossref
Nathaniel J.T. Monck & Guy A. Kennett. 2008. Progress in Medicinal Chemistry Volume 46. Progress in Medicinal Chemistry Volume 46 281 390 .
Øyvind Hauso, Björn I. Gustafsson, Jan P. Loennechen, Astrid K. Stunes, Ivar Nordrum & Helge L. Waldum. (2007) Long-term serotonin effects in the rat are prevented by terguride. Regulatory Peptides 143:1-3, pages 39-46.
Crossref
J. GOSSELLIN, J. A. WREN & S. J. SUNDERLAND. (2007) Canine obesity ? an overview. Journal of Veterinary Pharmacology and Therapeutics 30:s1, pages 1-10.
Crossref
Jeffrey A. Kramer, John E. Sagartz & Dale L. Morris. (2007) The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates. Nature Reviews Drug Discovery 6:8, pages 636-649.
Crossref
Wei Ni, Gregory D. Fink & Stephanie W. Watts. (2007) The 5-Hydroxytryptamine 2A Receptor Is Involved in (+)-Norfenfluramine-Induced Arterial Contraction and Blood Pressure Increase in Deoxycorticosterone Acetate-Salt Hypertension . Journal of Pharmacology and Experimental Therapeutics 321:2, pages 485-491.
Crossref
Alice C. Dutton & Nicholas M. Barnes. (2006) Anti-obesity pharmacotherapy: Future perspectives utilising 5-HT2C receptor agonists. Drug Discovery Today: Therapeutic Strategies 3:4, pages 577-583.
Crossref
Björn M. Nilsson. (2006) 5-Hydroxytryptamine 2C (5-HT 2C ) Receptor Agonists as Potential Antiobesity Agents . Journal of Medicinal Chemistry 49:14, pages 4023-4034.
Crossref
David Hepworth, Philip A. Carpino & Shawn C. Black. 2006. Annual Reports in Medicinal Chemistry Volume 41. Annual Reports in Medicinal Chemistry Volume 41 77 97 .
Bruce N. Rogers & Christopher J. Schmidt. 2006. Annual Reports in Medicinal Chemistry Volume 41. Annual Reports in Medicinal Chemistry Volume 41 3 21 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.